ANI Pharmaceuticals
ANIP
#5176
Rank
NZ$3.04 B
Marketcap
NZ$134.13
Share price
-1.12%
Change (1 day)
19.63%
Change (1 year)

EPS for ANI Pharmaceuticals (ANIP)

EPS in 2026 (TTM): NZ$7.08

According to ANI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ$7.10. In 2025 the company made an earnings per share (EPS) of NZ$6.05 an increase over its 2024 EPS that were of NZ-$1.93.

EPS history for ANI Pharmaceuticals from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$7.0817.06%
2025NZ$6.05-412.5%
2024NZ-$1.93
2022NZ-$5.25-6.46%
2021NZ-$5.6172.87%
2020NZ-$3.25-476%
2019NZ$0.86-62.12%
2018NZ$2.28
2015NZ$2.31-47.66%
2014NZ$4.42-142.11%
2013NZ-$10.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$12.13 70.80%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.26-68.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
NZ$11.35 59.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
NZ$0.79-88.81%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
NZ-$4.35-161.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$7.36-203.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.37-66.67%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Royalty Pharma
RPRX
NZ$3.29-53.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
NZ-$43.67-715.09%๐Ÿ‡บ๐Ÿ‡ธ USA